Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00AHV
|
||||
| Former ID |
DIB000417
|
||||
| Drug Name |
SKL-PD
|
||||
| Synonyms |
SKA-PD-01; Monoamine oxidase B inhibitor (Parkinson's disease), SK Life Science
|
||||
| Indication | Central nervous system disease [ICD10:G00-G99] | Investigative | [543639] | ||
| Company |
SK Life Science
|
||||
| Target and Pathway | |||||
| Target(s) | Amine oxidase [flavin-containing] B | Target Info | Inhibitor | [543639] | |
| KEGG Pathway | Glycine, serine and threonine metabolism | ||||
| Arginine and proline metabolism | |||||
| Histidine metabolism | |||||
| Tyrosine metabolism | |||||
| Phenylalanine metabolism | |||||
| Tryptophan metabolism | |||||
| Drug metabolism - cytochrome P450 | |||||
| Metabolic pathways | |||||
| Serotonergic synapse | |||||
| Dopaminergic synapse | |||||
| Cocaine addiction | |||||
| Amphetamine addiction | |||||
| Alcoholism | |||||
| Pathway Interaction Database | Alpha-synuclein signaling | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.